Bio-Techne Corp (TECH) is a Healthcare · Biotechnology company listed on NASDAQ. Price $72.33 (-0.11%), Market cap $7.00B, P/E ratio 63.91, 52-week low–high $44.74 ~ $71.38.
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow
Financial statements, price targets, institutional (13F) holdings and related news for Bio-Techne Corp are updated in real time on BlackAll Trade.
Bio-Techne Corp trades at $72.33 (-0.11%). Real-time quotes and charts are available on BlackAll Trade.
Bio-Techne Corp has a market cap of about $7.00B. Its P/E ratio is 63.91.
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worl